The effect of cardiac angiography timing, contrast media dose, and preoperative renal function on acute renal failure after coronary artery bypass grafting  by Medalion, Benjamin et al.
Medalion et al Acquired Cardiovascular DiseaseThe effect of cardiac angiography timing, contrast media dose, and
preoperative renal function on acute renal failure after coronary
artery bypass graftingBenjamin Medalion, MD,a Hilit Cohen, MD,a Abid Assali, MD,b Hana Vaknin Assa, MD,b
Ariel Farkash, MD,a Eitan Snir, MD,a Erez Sharoni, MD,a Philip Biderman, MD,a Gai Milo, MD,c
Alexander Battler, MD,b Ran Kornowski, MD,b and Eyal Porat, MDaFrom th
Rabin
Sackl
Disclos
Receive
publi
Address
Rabin
benja
0022-52
Copyrig
doi:10.1
A
C
DObjective: Our objective was to assess the effect of the timing of cardiac angiography, contrast media dose, and
preoperative renal function on the prevalence of acute renal failure after cardiac surgery.
Methods: Data on 395 consecutive patients who underwent coronary artery bypass grafting were prospectively
collected. Creatinine clearance was estimated by the Cockcroft–Gault equation. Patients were divided into 3
groups according to the time between cardiac angiography and surgery (group A,  1 day; group B,> 1
day and  5 days; group C,>5 days). Patients who underwent a salvage operation or were receiving dialysis
before surgery were excluded. Acute renal failure was defined as 25% decrease from baseline of estimated
creatinine clearance and estimated creatinine clearance of 60 mL/min or less on postoperative day 3. Owing
to differences in preoperative characteristics between groups, propensity score analysis was used to adjust those
differences.
Results: Acute renal failure developed in 13.6% of patients. Hospital mortality was 3.3% and was higher in pa-
tients in whom acute renal failure developed (22%) versus those in whom it did not (0.3%; P<.001). Multivari-
able analysis identified preoperative estimated creatinine clearance of 60 mL/min or less (odds ratio [OR], 7.1),
operation within 24 hours of catheterization (OR ¼ 3.7), use of more than 1.4 mL/kg of contrast media (OR ¼
3.4), lower hemoglobin level (OR ¼ 1.3), older age (OR ¼ 1.1), and lower weight (OR ¼ 0.95) as independent
predictors of postoperative acute renal failure. Analysis of interaction between contrast dose and time of surgery
revealed that high contrast dose (>1.4 mL/kg) predicted acute renal failure if surgery was performed up to 5 days
after angiography.
Conclusions: Whenever possible, coronary bypass grafting should be delayed for at least 5 days in patients
who received a high contrast dose, especially if they also have preoperative reduced renal function. (J Thorac
Cardiovasc Surg 2010;139:1539-44)Acute renal failure (ARF) has been shown to be associated
with worse outcome after cardiac surgery.1-4 Contrast-in-
duced nephropathy (CIN) is a common cause of new
ARF5,6 and is related in part to the amount of contrast
used.7 As such, the timing between angiography and sur-
gery may be an important factor in the development of
ARF. The purpose of this study was to identify the associ-
ation between time of angiography, time of surgery, amount
of contrast used, and postoperative ARF and its conse-
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Study Population
This is a retrospective study based on a local database in which data are
prospectively collected. The database was approved by the hospital ethics
committee for research purposes. The database includes preangiography,
angiography, operative, and perioperative data. To have as homogeneous
a group of patients and as complete and reliable data as possible, the study
population included only patients having isolated first-time coronary artery
bypass grafting (CABG) who were catheterized and operated on in our fa-
cility with the use of cardiopulmonary bypass. Patients referred for surgery
from other hospitals were excluded. Patients who required a salvage opera-
tion or were receiving dialysis before surgery were also excluded. Between
January 2006 and July 2007, 395 patients fulfilled these criteria and served
as the study population.
Data Definitions and End Points
We estimated creatinine clearance (eClCr) for all patients before angiog-
raphy and on postoperative day 3 by the Cockcroft–Gault formula,8 ([140
age] $ body weight [kg]/serum creatinine [mg/dL] $ 72) (multiply by 0.85 in
women). Preangiography renal failure was defined as eClCr of 60 mL/min
or less. This is consistent with moderate renal dysfunction (level 3 of the Na-
tional Kidney Foundation classification).9 The primary end point of the
study was development of ARF after surgery, defined as absolute eClCr
of 60 mL/min or less on postoperative day 3, in addition to 25% decrease
in eClCr on postoperative day 3 relative to preangiography value, consistentdiovascular Surgery c Volume 139, Number 6 1539
Abbreviations and Acronyms
ARF ¼ acute renal failure
CABG ¼ coronary artery bypass grafting
CIN ¼ contrast-induced nephropathy
eClCr ¼ estimated creatinine clearance
ICU ¼ intensive care unit
OR ¼ odds ratio
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as upper 25% values of contrast administered per kilogram. In this study, it
was found to be 1.4 mL/kg. Secondary end points of the study were perio-
perative mortality defined as in-hospital mortality or 30-day mortality, pro-
longed intensive care unit (ICU) stay, and prolonged hospital stay (from
operation to discharge).
Angiographic Protocol
Low-osmolarity contrast (Ultravist; Schering AG, Berlin, Germany) is
used routinely in all patients. In patients with an eClCr of 60 mL/min or
less before angiography, known nephrotoxic medications are discontinued
24 hours before angiography. In addition, hydration with 1000 mL of nor-
mal saline solution is performed over several hours before the procedure. A
dose of 1200 mg N-acetylcysteine is administered every 12 hours, 1 day be-
fore angiography and 1 day after angiography (patients operated on the
same day as angiography did not get the postangiography dose). This pro-
tocol is supported by current knowledge that the aforementioned measures
reduce the prevalence of CIN.10
Data Analysis
We divided our study population into 3 groups on the basis of the time
interval between angiography and surgery: group A, interval 1 day or less
(n ¼ 153); group B, interval more than 1 day and less than 5 days (n ¼
120); and group C, interval 5 days or more (n ¼ 122). An interval of 5
days was selected to make sure that CIN had already peaked. An interval
of 1 day was selected to isolate higher risk patients in whom same-day sur-
gery was mandatory. We used the logistic EuroSCORE model to predict
perioperative mortality for each patient11 and a CIN score, as suggested
by Mehran and associates,7 to predict postcatheterization CIN. The higher
the CIN score, the higher the probability that CIN would develop after cath-
eterization. Preoperative and operative characteristics are displayed in Table
1. Several differences between groups are apparent. There is a higher rate of
diabetes and hypertension in group C, the creatinine level is higher, and
eClCr is lower in group C. These factors affect CIN score, which is higher
in this group. In contrast, more patients in group A had unstable angina and
were operated on urgently, reflected by higher perioperative predicted mor-
tality (EuroSCORE).
Adjustment for patient selection. To further adjust for patient
selection and differences between patients, based on all preoperative vari-
ables, we used a saturated multinomial logistic regression model to calculate
the probability that a patient would belong to 1 of the 3 groups. These pro-
pensity scores were later used in multivariable logistic regressions as a way
for better adjustment of the preoperative differences.12,13
To compare between groups, we used 1-way analysis of variance with
post hoc Bonferroni pairwise comparisons for normally distributed contin-
uous variables and the Kruskal–Wallis test for abnormally distributed con-
tinuous variables. For univariate outcome analysis, we compared normally
distributed continuous variables by the t test and abnormally distributed
continuous variables by the Mann–Whitney test. Categorical variables
were compared br c2 or Fisher’s exact test, as appropriate. Several multivar-
iable binary logistic regression models, with forward conditional variable1540 The Journal of Thoracic and Cardiovascular Surselection, were developed to identify independent associations with out-
come. Propensity score was forced into all models. Analysis of interaction
between time to surgery, eClCr, and contrast dose was also performed to
search for additive effects. Each model was performed once with preopera-
tive variables only and once with both preoperative and intraoperative vari-
ables. We included all preoperative and intraoperative variables in Table 1
in the models except CIN and EuroSCORE. In addition, we used eClCr and
contrast dose in both its continuous forms and then in separate models in its
categorical forms for better clinical inference, inasmuch as eClCr calcula-
tion is based on age, sex, serum creatinine, and weight. When eClCr was
studied, the other variables were omitted and vice versa to reduce colinearity
and redundant information.
Reliability of the analysis. To ascertain the reliability of our find-
ings, we used bootstrap aggregation (bagging) from automated analysis of
1000 bootstrap data sets. Variables appearing in 50% or more of the models
were retained as risk factors.14
Analysis was performed with SPSS 14 for Windows (SPSS, Inc, Chi-
cago, Ill).
We all had full access to the data and take responsibility for its integrity.
All of us have read and agree to the manuscript as written.RESULTS
Primary End Point
Of 395 patients studied, 54 (13.6%) had postoperative
ARF.
Univariate analysis. Univariate analysis identified several
preoperative variables to be associated with the development
of postoperative ARF (Table 2). Older age, female gender,
advanced New York Heart Association class, diabetes,
lower weight, lower hemoglobin level, and higher serum
creatinine level were all found to have such an association.
Of specific note are lower eClCr (52% vs 11% of patients
had preoperative eClCr 60 mL/min in the presence and ab-
sence of postoperative ARF, respectively; P< .001), higher
contrast dose (43% vs 20% of patients received contrast
dose  1.4 mL/kg in the presence and absence of postoper-
ative ARF, respectively; P< .001), and shorter interval be-
tween catheterization and surgery (20% vs 12% vs 8% in
groups A, B, and C, respectively; P ¼ .02), which increased
postoperative ARF. Measured operative variables did not
seem to be associated with ARF. CIN score was higher in
those who in whom ARF developed (Table 2).
Multivariable analysis. Multivariable logistic regression
identified several risk factors to be associated with develop-
ment of postoperative ARF (Table 3). Preoperative eClCr of
60 mL/min or less, contrast dose of 1.4 mL/kg or more, op-
eration within 1 day from angiography, and lower preopera-
tive hemoglobin levels were found to be independently
associated with postoperative ARF, with and without pro-
pensity adjustment. These variables also appeared more
than 50% of the time as predictors in the 1000 automatic
bootstrap analysis (see Methods) and, as such, appear to
be reliable predictors. When analyzed with or without eClCr
in the model, older age and lower weight also were risk fac-
tors for postoperative ARF development. Serum creatinine
did not turn out to be an independent predictor for postoper-
ative ARF. When the interaction of contrast dose of 1.4 mL/gery c June 2010
TABLE 1. Preoperative and operative characteristics
Group A (n ¼ 153) Group B (n ¼ 120) Group C (n ¼ 122) P value
Preoperative
Age (y) 65.7  11 66.2  10 66  11 .89
Sex (female) 34 (22) 27 (22) 27 (18) .99
NYHA class III or IV 5 (3) 2 (2) 2 (2) .43
Unstable angina 88 (57) 35 (29) 32 (26) .01
Urgent operation 26 (17) 6 (5) 4 (3) <.001
Diabetes 48 (31) 40 (33) 60 (49) .02
Hypertension 94 (61) 85 (71) 94 (77) .02
Smoking history 75 (49) 62 (52) 57 (47) .74
CVA 14 (9) 12 (10) 11 (9) .96
PVD 19 (12) 15 (13) 22 (18) .34
LVEF (%) 53  9 55  8 54  10 .45
Weight (kg) 78  12 77  12 79  13 .47
Hb (g/dL) 13.5  1.7 13.4  1.5 13.3  1.8 .63
Creatinine (mg/dL) 0.94  0.26 1.01  0.4 1.07  0.6 .025*
eClCr (mL/min) 88  26 82  22 79  27 .02*
eClCr (60 mL/min) 20 (13) 18 (15) 26 (21) .17
Contrast used (mL/kg) 1.1  0.7 1.2  0.6 1.1  0.5 .17
Contrast used (1.4 mL/kg) 39 (25) 30 (25) 23 (19) .38
CIN score 3.3  3 3.4  3 4.2  3 .05*
EuroSCORE (%) 7  4.3 5.4  4.4 5.2  4.3 <.001y
Operative
No. of grafts 3 (1-6) 3 (1-6) 3 (1-6) .72
XCT (min) 68  25 61  21 72  28 .26
CPBT (min) 84  32 78  28 90  39 .4
Data are presented as mean  standard deviation or number of cases (percent), except for number of grafts, given as median (range). NYHA, New York Heart Association; CVA,
cerebrovascular accident; PVD, peripheral vascular disease; LVEF, left ventricular ejection fraction; Hb, hemoglobin; eClCr, estimated creatinine clearance; CIN, contrast-induced
nephropathy; XCT, crossclamp time; CPBT, cardiopulmonary bypass time. *Group A versus C; ygroup A versus B and C.
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group), being in group C (more than 5 days between angiog-
raphy and surgery) was found to be protective in the pres-
ence of a contrast dose of 1.4 mL/kg or more (relative to
groups A and B; P ¼ .02). Graphic demonstration of the
probability for the development of postoperative ARF is pre-
sented by the 95% confidence interval bars in Figure 1, cat-
egorized by contrast dose. It can be appreciated that surgery
performed after 5 days from angiography carries a similar
low risk of ARF regardless of the amount of contrast used.
This is in contrast to surgery performed up to 5 days from
angiography, which carries a higher risk of ARF when
high contrast dose is used. All models showed good fit
and calibration with nonsignificant Hosmer and Lemeshow
tests (P> .4) and receiver operating curve c-statistics (area
under the curves>0.7; P< .05).Secondary End Points
Postoperative length of stay was longer in patients in
whom ARF developed (Table 2). Prolonged ICU stay
(48 hours) was present in 25% versus 10% in those in
whom ARF did and did not develop, respectively (P ¼
.004). Prolonged hospital stay (10 days) was present in
12% versus 5% in those in whom ARF did and did not de-The Journal of Thoracic and Carvelop, respectively (P ¼ .05). Overall perioperative mortal-
ity was 3.3%. It was 0.3% when no ARF developed versus
22% when ARF developed (P< .001).Discrimination Power
Inasmuch as the current study is too small to allow an in-
dependent scoring system to be developed to predict ARF
after CABG, we assessed the discrimination power of the
CIN score to predict postoperative ARF. We also modeled
the time interval variable with CIN score in a multivariable
logistic regression and assessed its ability to predict ARF.
The predicted probability to develop ARF calculated from
the multivariable analysis, the CIN score, and the predicted
probability from the CIN and time interval model were used
to generate receiver operating curves. Prediction from the
multivariable model showed the best discrimination with
area under the curve (c-statistics) of 0.88. It was 0.84 for
the combined CIN score and time interval, and it was 0.82
for the CIN score alone.DISCUSSION
ARF remains a major complication of CABG that is
strongly associated with worse outcome.1-4 Indeed, in this
study, patients in whom ARF developed had higherdiovascular Surgery c Volume 139, Number 6 1541
TABLE 2. Preoperative, operative, and postoperative univariate
analysis of ARF
No ARF
(n ¼ 341)
ARF
(n ¼ 54)
P
value
Preoperative
Age (y) 65  10 74  11 <.001
Sex (female) 70 (21) 18 (33) .04
NYHA class III or IV 5 (2) 4 (7) .05
Unstable angina 133 (39) 22 (41) .6
Urgent operation 30 (9) 6 (11) .6
Diabetes 121 (35) 28 (52) .004
Hypertension 232 (68) 41 (76) .25
Smoking history 171 (50) 23 (43) .3
CVA 31 (9) 6 (11) .64
PVD 51 (15) 5 (9) .3
LVEF (%) 54  9 53  10 .27
Weight (kg) 79  12 73  13 <.001
Hb (g/dL) 13.6  1.6 12.3  1.8 <.001
Creatinine (mg/dL) 0.98  0.4 1.1  0.4 <.001
eClCr (mL/min) 86  25 67  21 <.001
eClCr (60 mL/min) 36 (11) 28 (52) <.001
Contrast used (mL/kg) 1.1  0.5 1.3  0.8 .03
Contrast used (1.4 mL/kg) 69 (20) 23 (43) <.001
Time to surgery .02
1 day (group A) 123 (80) 30 (20)
1–5 days (group B) 106 (88) 14 (12)
5 days (group C) 112 (92) 10 (8)
CIN score 3  3 7  4 <.001
EuroSCORE (%) 5  3 7.5  4 <.001
Operative
No. of grafts 3 (1-6) 3 (1-6) .7
XCT (min) 67  26 66  22 .87
CPBT (min) 85  34 80  24 .55
Postoperative
eClCr on day 3 (mL/min) 87  32 50  21 <.001
ICU stay (h) 35  69 55  112 .003
Prolonged ICU stay (>48 h) 32 (10) 12 (25) .004
Hospital stay (d) 5.8  3.7 7.2  4.6 .03
Prolonged hospital stay (>10 d) 16 (5) 6 (12) .05
Perioperative mortality 1 (0.3) 12 (22) <.001
Data are presented as mean  standard deviation or number of cases (percent), except
for number of grafts, given as median (range). ARF, Acute renal failure; NYHA, New
York Heart Association; CVA, cerebrovascular accident; PVD, peripheral vascular dis-
ease; LVEF, left ventricular ejection fraction; Hb, hemoglobin; eClCr, estimated cre-
atinine clearance; CIN, contrast-induced nephropathy; XCT, crossclamp time; CPBT,
cardiopulmonary bypass time.
TABLE 3. Independent risk factors associated with ARF
OR 95% CI P value Reliability (%)
eClCr (60 mL/min) 7.14 3–16 <.001 95
Contrast used (1.4 mL/kg) 3.4 1.5–7.7 .004 70
Group A ( 1 d) 3.7 1.4–8.3 .07 73
Hb (g/dL) 1.3 1.07–1.72 .01 75
Age (y) 1.1 1.06–1.16 <.001 90
Weight (kg) 0.95 0.92–0.99 .005 64
ARF, Acute renal failure; OR, odds ratio; CI, confidence interval; reliability, percent of
1000 bootstrap analyses; eClCr, estimated creatinine clearance; Hb, hemoglobin.
Odds ratios for Hb, age, and weight represent unit change, for eClCr60 and contrast
used 1.4 represent presence of the variable relative to its absence, and for groups A
and B represent comparison to the average effect of group C.
Time to surgery (days)
>51-5<=1
AR
F 
(%
)
40
30
20
10
0
yes
no
Contrast>=1.4 ml/kg
FIGURE 1. Predicted probability for the development of postoperative
acute renal failure (ARF) according to interval between angiography and
surgery and contrast dose used. Bars represent 95% confidence interval.
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Dperioperative mortality and longer ICU and hospital lengths
of stay. Several preoperative and operative risk factors for
development of ARF after cardiac surgery were identified;
among them were older age, decreased preoperative eClCr,
and reduced left ventricular function, to go along with iso-
lated CABG, previous CABG, diabetes mellitus, congestive
heart failure, urgent operation, and cardiopulmonary bypass
time.1-4,15-17 Multiple mechanisms contribute to the renal
damage, including nonpulsatile flow, embolization, trauma
to the blood constituents, hypothermia, and activation of
known inflammatory pathways.181542 The Journal of Thoracic and Cardiovascular SurMost studies have ignored CIN, a common cause of post-
angiography ARF. CIN develops in up to 10% of patients
with normal renal function and may develop in up to 25%
of patients with pre-existing renal impairment.10 Baseline re-
nal impairment, diabetes mellitus, congestive heart failure,
and higher doses of contrast media increase the risk of
CIN.7,10,19 In the presence of a reduced nephron mass, the
remaining nephrons are vulnerable to injury. Iodinated con-
trast, after causing a brief (minutes) period of vasodilation,
causes sustained (hours to days) intrarenal vasoconstriction
and ischemic injury. The ischemic injury sets off a cascade
of events largely driven by oxidative injury, causing death
of renal tubular cells. If a sufficient mass of nephron units
are affected, then a recognizable rise in serum creatinine
will occur.20 Several measures have been suggested to min-
imize CIN.6,10,19 Low-osmolarity contrast, hydration, and
cessation of nephrotoxic medications are suggestedgery c June 2010
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tients (see Methods). Inasmuch as CIN is usually a time-lim-
ited phenomenon, with an effect that peaks after 3 to 5 days
from contrast administration, and inasmuch as contrast dose
is an important factor in development of CIN, surgery soon
after angiography may impose a second insult to the kidneys
and induce ARF. High contrast dose was an independent
predictor of postoperative ARF in this study, despite optimal
protocol adherence to minimize CIN. However, its effect
was mainly during the first 5 days after angiography, as de-
scribed in the multivariable analysis by the interaction of
contrast dose with time of surgery and graphically demon-
strated in Figure 1. The association of high contrast dose
and operation up to 5 days after angiography had an additive
effect on the prevalence of ARF. Several reasons why pa-
tients received high dose of contrast media were identified.
Ventriculograms were rarely performed in our institute, es-
pecially in patients with renal dysfunction, and are probably
not the cause of high contrast dose. Contrast volume was
determined by the number of injections and projections
required for good quality of image and the need for delinea-
tion of the anatomy per request of the surgeon.
Other independent risk factors identified were older age,
lower hemoglobin level, lower weight, and moderate preop-
erative renal failure. Lower hemoglobin level requires spe-
cial attention. If it is truly an independent risk factor, then
measures to increase hemoglobin preoperatively may prove
to be beneficial. However, if lower hemoglobin is just a co-
variate to renal dysfunction, despite extensive statistical
analysis, such measures are probably unnecessary. Future
studies may clarify this issue.
Del Duca and associates16 found that surgery within 5
days of angiography was independently associated with
postoperative ARF and mortality. Their study included sev-
eral types of operations, including valve surgery with or
without CABG and other operations that were already iden-
tified as risk factors for development of postoperative
ARF.21 Moreover, these more complex operations increase
cardiopulmonary bypass time, which by itself increases the
risk for ARF.3,15 In addition, inasmuch as contrast dose
was not collected, and whether patients had any measure
to reduce CIN is unclear, the association with these impor-
tant factors could not be studied.
Ranucci and associates17 identified surgery within 1 day
of angiography as a risk factor for postoperative ARF.
They also studied mixed operations including reoperations
that may represent more complicated cases in which ARF
is likely to develop owing to multiple comorbidities.3 In con-
trast to our study, although suggested in univariate analysis,
they failed to associate contrast dose with ARF in multivari-
able analysis. One explanation is that they used median con-
trast dose as their categorical cutoff point, which may not be
high enough. We used the upper quartile of contrast dose as
our categorical cutoff point and could show such an associ-The Journal of Thoracic and Caration. A second, and maybe more important, explanation re-
lates to time of surgery. Inasmuch as CIN peaks after 3 to 5
days, CIN and ARF were more likely to develop in some
patients who were operated on more than 1 day after angio-
graphy. By dividing our patient population into 3 groups we
could show the CIN effect up to 5 days after angiography.
They also used peak creatinine as their end point measure
for development of ARF. This may further bias the results
by capturing complicated cases in which ARF developed
as part of a broader multiorgan failure, not directly related
to time after angiography. Brown and associates,22 studied
same-day angiography and elective valve surgery and con-
cluded that in properly selected patients this is a safe option
that carries little impact on postoperative ARF. They had no
comparison group, they did not collect contrast dose, and
more important, they excluded patients with significant renal
dysfunction (serum creatinine>1.8 mg/dL). Indeed, even in
our study, elective patients who had near normal preopera-
tive renal function and received low contrast dose could un-
dergo surgery safely immediately after angiography.
Owing to the worse outcome associated with ARF after
CABG, a scoring system to predict its development will
be important for both patient selection and risk stratification.
This study is too small to develop and validate such a score,
but we could show that even the angiographic CIN score can
reasonably predict ARF in the surgical population. The ad-
dition of time from angiography to surgery can further refine
the prediction and may serve as a starting point of surgical
score calculation in a future larger study.
The main study limitation is its retrospective nature. To
reduce the effect of this limitation, we have applied several
actions. We excluded patients who had conditions that may
have increased the risk for ARF. We excluded those who
were receiving preoperative dialysis, those whose operations
were done on a truly emergency basis, and those who had
other operations in addition to CABG. We understood that
despite exclusion of emergency cases, some patients who
were operated on within 24 hours of angiography were
higher risk patients, in whom same-day surgery was un-
avoidable, and may have been in worse preoperative condi-
tion and more prone to the development of ARF. Despite
this, we included all those patients operated on within 24
hours in 1 group (group A). We also used a propensity scor-
ing technique to correct for selection bias and performed
bootstrap analysis to investigate how reliable the risk factors
were that we identified.
It is important to emphasize that low-osmolarity contrast
media (Ultravist) was used in all patients in this study. A
higher rate of ARF is anticipated with the use of high-osmo-
larity contrast agents. Patients who had same-day surgery
did not get the 12-hour postangiography N-acetylcysteine.
After the results of this study, we continue to use N-acetyl-
cysteine administration for 1 day after surgery. On the basis
of this study, we can suggest that unless emergency CABGdiovascular Surgery c Volume 139, Number 6 1543
Acquired Cardiovascular Disease Medalion et al
A
C
Dis absolutely indicated, surgery should be delayed for more
than 5 days after angiography in patients who receive a high
contrast dose, especially if they also have preoperative re-
duced renal function. If a patient is anticipated to require
early operation, an attempt to minimize contrast dose is cru-
cial, especially in the presence of reduced renal function. In
addition, all measures should be taken to reduce ARF by us-
ing low-osmolarity contrast agent, with the lowest possible
volume, good hydration, and probably N-acetylcysteine
administration.References
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